Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients
PaperCitations, authors & open-access status
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 84 citations, 2019 year and green oa status.
84
Citations
2019
Year
green
OA Status